Literature DB >> 31710948

Anticonvulsive and neuroprotective effects of aqueous and methanolic extracts of Anacyclus pyrethrum root in kainic acid-induced-status epilepticus in mice.

Houria Manouze1, Otmane Bouchatta1, Mohamed Bennis1, Zahra Sokar1, Saâdia Ba-M'hamed2.   

Abstract

PURPOSE: Epilepsy is a chronic neurological disorder characterized by spontaneous and recurrent seizures. The currently available synthetic antiepileptic drugs have a limited efficacy and are associated with a wide range of side effects. In Ayurveda, Anacyclus pyrethrum root (APR) has been used as a traditional antiepileptic remedy. The aim of the present study is to evaluate the anticonvulsive and neuroprotective effects of aqueous and methanol extracts of Anacyclus pyrethrum root (AEAPR and MEAPR) on experimental model of status epilepticus (SE).
METHODS: Twenty four male mice were divided into four groups. The control and KA groups had free access to tap water for 5 days before the intraperitoneal injection of distillated water or kainic acid (KA; 30 mg/kg), respectively. In the treated groups, mice received extracts solutions MEAPR and AEAPR in drinking water at the concentration of 5 g/l for 5 days. At the fifth day, animals received intraperitoneal injection of KA. The behavioral changes latency of seizures, the number of wet dog shakes (WDS) and the mortality were observed over 6 h. Thereafter, the mice were sacrificed for immunohistochemical studies.
RESULTS: Pretreatment with MEAPR and AEAPR decreases significantly the frequency of WDS (32.5% and 43.9%, p < 0.01; respectively), and increases considerably the latent period (77.9% and 91.9%, p<0.01; respectively) between the injection of the KA and the appearance of the SE as compared to the KA group. The duration and severity of seizure in the MEAPR or AEAPR-pretreated groups were significantly lower (p < 0.01 and p < 0.05 or p < 0.01; respectively) than those in the KA group. These behavioral results were confirmed by the immunohistochemical study at the level of the hippocampus, in which the c-FOS and GFAP expression of both MEAPR and AEAPR-treated animals largely reduced (p < 0.001) the number of labelled cells with respect to the group, which received the KA alone.
CONCLUSION: Our results showed that the MEAPR and AEAPR have anticonvulsive effect and putative neuroprotective effect against seizures induced by KA. Further studies are required to identify its active ingredients responsible for the observed effects.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anacyclus pyrethrum; Anticonvulsant; Kainic acid; Mice; Neuroprotective

Mesh:

Substances:

Year:  2019        PMID: 31710948     DOI: 10.1016/j.eplepsyres.2019.106225

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  3 in total

1.  Evaluation of the acute toxicity of the extracts of Anacyclus pyrethrum var. pyrethrum (L.) and Anacyclus pyrethrum var. depressus Maire in Swiss mice.

Authors:  Fatima Zahra Jawhari; Abdelfattah El Moussaoui; Hamada Imtara; Hamza Mechchate; Imane Es-Safi; Mohamed Bouhrim; Loubna Kharchoufa; Achraf Miry; Dalila Bousta; Amina Bari
Journal:  Vet World       Date:  2021-02-22

2.  Anacyclus pyrethrum (L): Chemical Composition, Analgesic, Anti-Inflammatory, and Wound Healing Properties.

Authors:  Fatima Zahra Jawhari; Abdelfattah El Moussaoui; Mohammed Bourhia; Hamada Imtara; Hamza Mechchate; Imane Es-Safi; Riaz Ullah; Essam Ezzeldin; Gamal A Mostafa; Andriy Grafov; Samir Ibenmoussa; Dalila Bousta; Amina Bari
Journal:  Molecules       Date:  2020-11-23       Impact factor: 4.411

3.  Reproductive Biology of the Two Varieties of Anacyclus pyrethrum L.-Anacyclus&amp;nbsp;pyrethrum var. pyrethrum (L.) Link and Anacyclus pyrethrum var. depressus (Ball.) Maire-An Endemic Endangered Species.

Authors:  Fatima Zahra Jawhari; Hamada Imtara; Abdelfattah El Moussaoui; Hind Khalis; Imane Es-Safi; Omkulthom Al Kamaly; Asmaa Saleh; Mohammad Khalid Parvez; Raja Guemmouh; Amina Bari
Journal:  Plants (Basel)       Date:  2022-09-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.